These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3771434)

  • 1. Doxycycline in respiratory infections: a re-assessment after 17 years.
    Maesen FP; Davies BI; van Noord JA
    J Antimicrob Chemother; 1986 Oct; 18(4):531-6. PubMed ID: 3771434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone in acute purulent exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP
    J Antimicrob Chemother; 1984 Dec; 14(6):653-60. PubMed ID: 6097574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of doxycycline against respiratory pathogens.
    Butzler JP
    Chemotherapy; 1975; 21 Suppl 1():116-20. PubMed ID: 239836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J; Escoubas J; Fouche J; Mormede M
    Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
    Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
    Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aztreonam in patients with acute purulent exacerbations of chronic bronchitis: failure to prevent emergence of pneumococcal infections.
    Davies BI; Maesen FP; Teengs JP
    J Antimicrob Chemother; 1985 Mar; 15(3):375-84. PubMed ID: 3922936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxycycline and minocycline in the treatment of respiratory infections: a double-blind comparative clinical, microbiological and pharmacokinetic study.
    Maesen FP; Davies BI; van den Bergh JJ
    J Antimicrob Chemother; 1989 Jan; 23(1):123-9. PubMed ID: 2501265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Baur C
    J Antimicrob Chemother; 1987 Mar; 19(3):373-83. PubMed ID: 3494724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branhamella catarrhalis as an indirect pathogen.
    Wardle JK
    Drugs; 1986; 31 Suppl 3():93-6. PubMed ID: 3732085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branhamella catarrhalis respiratory infections in The Netherlands.
    Maesen FP; Davies BI
    Drugs; 1986; 31 Suppl 3():83-6. PubMed ID: 3732084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline in respiratory tract infections. A review of a multi-centre trial.
    Meier J
    Chemotherapy; 1975; 21 Suppl 1():130-5. PubMed ID: 239837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pefloxacin in acute exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP
    J Antimicrob Chemother; 1985 Sep; 16(3):379-88. PubMed ID: 3863811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
    Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K
    Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open randomised comparison of ofloxacin and doxycycline in lower respiratory tract infections.
    Harazim H; Wimmer J; Mittermayer HP
    Drugs; 1987; 34 Suppl 1():71-3. PubMed ID: 3481331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefpodoxime proxetil in the treatment of lower respiratory tract infections.
    Geddes AM
    Drugs; 1991; 42 Suppl 3():34-40. PubMed ID: 1726206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A; Janicka G; Krawiecka D; Kochanowska J
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections.
    Varon E; Levy C; De La Rocque F; Boucherat M; Deforche D; Podglajen I; Navel M; Cohen R
    Clin Infect Dis; 2000 Aug; 31(2):477-81. PubMed ID: 10987708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.